Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often due to the difficulty in identifying symptoms. When this condition is symptomatic or oligosymptomatic, it is associated with increased rates of hospitalization and mortality.

While current guidelines recommend valve replacement in cases of impaired ventricular function, available reports are not definitive regarding its implementation.

Researchers conducted a meta-analysis that included four randomized studies (EARLY TAVR, EVoLVeD, AVATAR, and RECOVERY), with a total of 1427 patients. Of these, 719 underwent early aortic valve replacement through surgical or transcatheter aortic valve replacement (SAVR or TAVR), while the rest underwent clinical follow-up (CF) alone.

Read also: 1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves.

With an average follow-up of four years, TAVR demonstrated a significant reduction in the rates of hospitalization due to cardiovascular causes or heart failure (combined rate: 14.6% vs. 31.9%; hazard ratio [HR]: 0.40; 95% confidence interval [CI]: 0.30–0.53; I² = 4%; p < 0.01) and in the incidence of stroke (combined rate: 4.5% vs. 7.2%; HR: 0.62; 95% CI: 0.40–0.97; I² = 0%; p = 0.03). However, there were no significant differences in all-cause mortality (combined rate: 9.7% vs. 13.7%; HR: 0.68; 95% CI: 0.40–1.17; I² = 61%; p = 0.17) or cardiovascular mortality (combined rate: 5.1% vs. 8.3%; HR: 0.67; 95% CI: 0.35–1.29; I² = 50%; p = 0.23). It is worth noting that the studies analyzed were highly heterogeneous.

Conclusion

In this meta-analysis of four randomized studies, early aortic valve replacement was associated with a significant reduction in hospitalization rates due to cardiovascular causes or heart failure, as well as in the incidence of stroke. However, there were no differences in all-cause mortality or cardiovascular mortality compared to clinical follow-up.

Original Title: Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis. 

Reference: Philippe Généreux, et al. JACC article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

Is Transcarotid Access a Safe Option in TAVI?

Transcatheter aortic valve implantation (TAVI) should preferably be conducted via transfemoral access, according to European guideline (in patients ≥75 years) and American guideline (in patients...

Endovascular Therapy for PE: Earlier Rather than Later Treatment, as in MI and Stroke?

Patients with pulmonary embolism (PE), whether intermediate-high or high risk, may progress to right ventricular (RV) dysfunction, leading to severe hemodynamic decompensation and significantly...

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Transcatheter aortic valve replacement (TAVR) has consolidated as treatment for severe symptomatic aortic stenosis, even in low risk patients. In this context, valve hemodynamic...

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

Atrial functional mitral regurgitation (aFMR), which results from atrial dilation without significant left ventricular dysfunction, accounts for approximately one-third of mitral regurgitation (MR) cases...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Is Transcarotid Access a Safe Option in TAVI?

Transcatheter aortic valve implantation (TAVI) should preferably be conducted via transfemoral access, according to European guideline (in patients ≥75 years) and American guideline (in patients...

Fasting versus No Fasting Before Percutaneous Cardiovascular Procedures

While the American Society of Anesthesiologists guidelines were updated in 2017 to allow for the intake of clear liquids up to two hours and...

Smoking and Its Impact on Cardiovascular Disease 10 Years After Coronary Angioplasty

Smoking is a well-established risk factor for atherosclerotic cardiovascular diseases. However, some historical reports have suggested a lower risk of adverse cardiovascular events in...